Results of the ZiPP study pave the way for genetic testing for Paget’s disease

There could be a brighter future for those affected by Paget's Disease of Bone. In this interview with Prof Rob Layfield, Prof Stuart Ralston said, “The results of the ZiPP* study will change clinical practice and pave the way for genetic testing to be offered to people with a family history of Paget’s so that the condition can be picked up and treated at an early stage”. *Zoledronate in the Prevention of Paget's (ZiPP) study. This video is part of the 2024 Paget's Awareness Day video series from the Paget's Association, a charity based in the UK.